| Literature DB >> 34067569 |
Esam Bashir Yahya1, A A Amirul2, Abdul Khalil H P S1, Niyi Gideon Olaiya3, Muhammad Omer Iqbal4, Fauziah Jummaat5, Atty Sofea A K6, A S Adnan5.
Abstract
The global transplantation market size was valued at USD 8.4 billion in 2020 and is expected to grow at a compound annual growth rate of 11.5% over the forecast period. The increasing demand for tissue transplantation has inspired researchers to find alternative approaches for making artificial tissues and organs function. The unique physicochemical and biological properties of biopolymers and the attractive structural characteristics of aerogels such as extremely high porosity, ultra low-density, and high surface area make combining these materials of great interest in tissue scaffolding and regenerative medicine applications. Numerous biopolymer aerogel scaffolds have been used to regenerate skin, cartilage, bone, and even heart valves and blood vessels by growing desired cells together with the growth factor in tissue engineering scaffolds. This review focuses on the principle of tissue engineering and regenerative medicine and the role of biopolymer aerogel scaffolds in this field, going through the properties and the desirable characteristics of biopolymers and biopolymer tissue scaffolds in tissue engineering applications. The recent advances of using biopolymer aerogel scaffolds in the regeneration of skin, cartilage, bone, and heart valves are also discussed in the present review. Finally, we highlight the main challenges of biopolymer-based scaffolds and the prospects of using these materials in regenerative medicine.Entities:
Keywords: aerogels; biocompatibility; biopolymers; regenerative medicine; scaffold; tissue engineering
Year: 2021 PMID: 34067569 PMCID: PMC8156123 DOI: 10.3390/polym13101612
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
The chronological evolution of tissue engineering and regenerative medicine.
| Scientist/s and Year | Type of Tissue | Scaffold Material | Remark | Ref |
|---|---|---|---|---|
| Indians in 600 BC. | Skin and cartilage. | Free gluteal fat. | Using secret cement for adhesion. | [ |
| Brancas in 1442. | Nose cartilage. | Isograft. | The nose of slave to his master. | [ |
| Boronio in 1804. | Skin substitute. | Autograft. | Auto-graft of full-thickness skin grafts on a sheep. | [ |
| Bunger in 1823. | Skin tissues. | Autograft. | Skin is taken from the thigh for the repair of nasal defects. | [ |
| Alexis Carrel in 1911. | Endothermal animal cells. | Thin layer of clotted plasma. | Recipient of Nobel Prize in Medicine for tissue culture. | [ |
| Blakemore et al. in 1954. | Vascular graft. | Silk handkerchief and Vinyon. | The first prosthetic vascular graft implanted in a human patient. | [ |
| Per Ingvar Brånemark in 1960s. | Bone tissue. | Titanium cylinder. | The establishment of the osseointegration concept. | [ |
| W. T. Green in the 1970s. | Cartilage tissue. | Spicules of bone. | Seeding cells onto spicules of bone and implanting them in nude mice. | [ |
| Vacanti et al. in 1988. | Different fetal and adult rat and mouse cells. | Polyanhydrides, polyglactin 910, and polyorthoester. | Successful transplantation of cells in synthetic biodegradable polymers. | [ |
| Stone et al. in 1997. | Meniscal cartilage. | Collagen-based scaffold. | No adverse immunological reactions were reported. | [ |
| Zein et al. in 2002. | Different human tissues. | Bioresorbable polymer. | Fused deposition modelling used for aerogel scaffold fabrication. | [ |
| Svensson et al. in 2005. | Cartilage tissue. | Bacterial cellulose scaffold. | Concluded a high potential for this biopolymer in tissue regeneration. | [ |
| Macchiarini et al. in 2008. | Engineered trachea. | Decellularized matrix of human donor trachea. | Removing all the antigens from donor trachea and seeding it with human stem cells. | [ |
| Norotte et al. in 2009. | Various vascular cell types. | Direct bioprinting. | Fully biological self-assembly approach for tissue engineering. | [ |
| Ahn et al. in 2010. | Skin tissue regeneration. | 3D collagen scaffolds. | The scaffold supported the migration and infiltration of cells. | [ |
| Zhou et al. in 2013. | Bone tissue. | Bio-nanocomposite scaffolds. | Using the electrospun technique. | [ |
| Inzana et al. in 2014. | Bone regeneration. | Calcium phosphate and collagen scaffolds | Using 3D printing technique to control the shape of scaffold. | [ |
| Vikingsson et al. in 2015. | Articular cartilage regeneration. | Polycaprolactone-polyvinyl alcohol. | The composite scaffold possesses great potential for articular cartilage. | [ |
| Na et al. in 2016. | Dental pulp regeneration. | 3D stem cell sheet-derived pellet. | Odontogenic stem cells used for designing 3D stem cell sheet-derived pellet. | [ |
| Lastra et al. in 2018. | Osteochondrogenesis regeneration. | Copolymer chitosan crosslinked scaffold | The nanostructured scaffold was highly biocompatible and non-cytotoxic. | [ |
| Ghosh et al. in 2019. | For bone repair and regeneration. | Injectable alginate–peptide scaffolds | The scaffold served as a biomaterial for bone regeneration. | [ |
| ElSheshtawy et al. in 2020. | Endodontics regeneration. | Plateletrich plasma-based scaffold | Using 2D radiographs and cone-beam computed tomography. | [ |
| Zeng et al. in 2021. | Retinal cell culture. | Polycaprolactone scaffolds. | Biomimetic kerateine aerogel electrospun scaffolds. | [ |
Figure 1Number of scientific publications on different tissue regeneration (search done through Science Direct on 1 May 2021).
Figure 2Schematic illustration of the tissue engineering process.
Biocompatibility and cytotoxicity of biopolymers in tissue engineering applications.
| Biopolymeric Scaffold | Cell Type | Conclusion | Ref |
|---|---|---|---|
| 3D porous cellulose scaffolds. | Osteoblast-like MG-63 cells. | The scaffold did not show any cytotoxic effect. | [ |
| Non-covalent sericin–chitosan scaffold. | Human dermal fibroblasts. | No cytotoxic effect for the scaffold was observed against the human skin cells. | [ |
| Recombinant collagen/hyaluronic acid composite scaffolds. | Mouse fibroblasts cells (L929 cells). | No cytotoxicity and good biodegradability was observed. | [ |
| Collagen- and elastin-based scaffolds. | Human umbilical vein endothelial cells. | The scaffolds were highly compatible and non-cytotoxic. | [ |
| Silk fibroin-based scaffolds. | Human fibroblast cells (GM07492). | High cellular viability and seemed to be non-cytotoxic. | [ |
| Propolis/sodium alginate scaffolds. | Human dermal fibroblasts (HFFF2). | The scaffolds were non-toxic at low concentrations. | [ |
| Gelatin hydrogels tissue scaffold. | Human pre-adipocytes (3T3-L1). | The scaffolds showed no cytotoxic effects on the cells. | [ |
| Nanocellulose- and elastin-based scaffolds. | Human fibroblast cells. | All the prepared scaffolds seemed to be non-cytotoxic and biocompatible. | [ |
| Hyaluronic acid/corn silk extract scaffold. | Mesenchymal stem cells. | High cellular differentiation without any cytotoxic effect. | [ |
| Salt leached silk fibroin-based scaffolds. | Human adipose stem cells. | The scaffolds were highly biocompatible and non-cytotoxic. | [ |
Figure 3Schematic illustration of the original principle of using biopolymer aerogel scaffolds in tissue regeneration.
Summary of the most used techniques for biopolymer aerogel scaffold fabrication.
| Technique | Principal | Ref |
|---|---|---|
| Electrospinning technique | Charged threads of biopolymeric solution or biopolymer melt are drawn using a special machine by high voltage electricity. | [ |
| Solvent casting and practical leaching technique | Dissolving the polymeric powder in suitable solvents containing salt particles, which are then evaporated with the salts leaching out. | [ |
| Freeze-drying technique | Freezing the dissolved polymer hydrogel and drying it under the vacuum to maintain the structural integrity of the hydrogel. | [ |
| Stereolithography technique | Computer-aided technique prints photosensitive liquid of biopolymer layer-by-layer using an ultraviolet laser. | [ |
| Injection molding technique | Melting and injecting the biopolymeric material into a mold, after which it cools and solidifies. | [ |
| Gas foaming technique | Dissolving the biopolymer in organic solvents and then inserting gases used to pressurize the modelled until it is full of gas bubbles. | [ |
| Selective laser sintering technique | The biopolymeric solution is printed by selective laser, which sinters the material in thin layers leading to 3D scaffold printing. | [ |
| Fused deposition modelling technique | Deposition of biopolymeric materials extruded layer-by-layer through a special nozzle to form 3D multiple layers scaffolds. | [ |
Figure 4Illustration of the 3D micro-porous regenerated bacterial cellulose/gelatin (3DMPrBC/G) tissue scaffold: (a) SEM images of the scaffold, (b) cell adhesion and proliferation after 3 days and 7 days of incubation, (c) experimental in vivo skin regeneration. Adapted with permission from ref. [125]. 2018 Elsevier.
Figure 5Schematic illustration of silk fibroin (SF), hyaluronic acid (HA), and sodium alginate (SA) composite scaffold for wound dressing and skin regeneration applied on an animal full-thickness burn model. Adapted with permission from ref. [130]. 2019 Elsevier.
Figure 6Schematic illustration of 3D printed electrospun scaffold for cartilage regeneration. Adapted with permission from ref. [137]. 2019 Elsevier.
Figure 7Biopolymer-based scaffolds in bone regeneration: (a) implantation of a chitosan/poly(lactide-co-glycolide) scaffold in a 15 mm surgical induced ulna defect and bone regeneration after 12 weeks showing the formation of bridges (adapted Adapted with permission from ref. [144]) 2010 Elsevier; (b) injecting the thermo-sensitive hyaluronic acid/corn silk extract composite scaffold containing β-tricalcium phosphate in defected bone for its regeneration (adapted with permission from ref. [95]) 2020 Elsevier.
Figure 8Schematic illustration of heart valve regeneration using biopolymer aerogel-based scaffolds.